DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62626-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)62626-5/fulltext
Title :
DB6 COMPARISON OF THE COST-EFFECTIVENESS FOR BASAL-BOLUS THERAPY OF TYPE-1 DIABETES USING INSULIN DETEMIR INSULIN ASPART OR HUMAN INSULIN-BASED REGIMENS IN THE NETHERLANDS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62626-5&doi=10.1016/S1098-3015(10)62626-5
First page :
Section Title :
Open access? :
No
Section Order :
63